z-logo
open-access-imgOpen Access
Report of rare and novel mutations in candidate genes in a cohort of hearing‐impaired patients
Author(s) -
Liu Min,
Liang Yue,
Huang Bixue,
Sun Jincangjian,
Chen Kaitian
Publication year - 2022
Publication title -
molecular genetics and genomic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.765
H-Index - 29
ISSN - 2324-9269
DOI - 10.1002/mgg3.1887
Subject(s) - genetics , proband , hearing loss , pedigree chart , gene , biology , candidate gene , genetic testing , mutation , in silico , exome sequencing , genetic heterogeneity , medicine , phenotype , audiology
Background Many hearing‐impaired patients carry mutations in rare or novel genes undetected in regular genetic hot regions/genes screening. Methods We collected clinical and genetic data from subjects with hearing loss who visited our department for genetic counseling. Next‐generation sequencing was conducted after 154 deafness‐related genes were captured using a designed genes panels in 14 unrelated families (37 participants). The results were filtered and assessed with in silico tools, in combination with pedigree mapping. Results Ten mutations in regular deafness genes ( GJB2 , SLC26A4 ) and uncommon genes ( OTOF , MYO7A , MYO15A , and KARS ) were detected, which constituted 57.2% of yielded rate. In particular, two patients with nonsyndromic deafness carried biallelic KARS mutations. In addition, we identified an unreported digenic mutational inheritance in GRP98 / USH2A genes in a proband with isolated hearing loss. Functional analyses and molecular modeling suggested the damaging consequence of these variants on encoded proteins. According to the variant pathogenicity guidelines, the 17 identified variants in total were classified as “pathogenic” or “likely pathogenic.” Conclusion The candidate mutations in deafness genes were suggested to be co‐segregated in at least 57.2% of the studied pedigrees. This is the new report of rare/novel mutations causing inherited hearing loss in Chinese.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here